Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 6, 2010, Pages 753-759

  Kheradmandnia, Soheila ^a   Vasheghani Farahani, Ebrahim ^a   Nosrati, Mohsen ^a   Atyabi, Fatemeh ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Controlled release; Ketoprofen; Solid lipid nanoparticles; Thermal characterization; Waxes

Indexed keywords

CARNAUBA WAX; COLLOIDAL CARRIERS; CONTROLLED RELEASE; DRUG ENTRAPMENT; DRUG LEAKAGE; DRUG RELEASE; INTERFACE PROPERTY; KETOPROFEN; MEAN PARTICLE SIZE; MIXED SURFACTANT; MODEL DRUGS; POLYDISPERSITY INDICES; POORLY WATER-SOLUBLE DRUGS; SOLID LIPID NANOPARTICLES; SURFACTANT COMPOSITION; SURFACTANT CONCENTRATIONS; THERMAL CHARACTERIZATION; TWEEN 80;

CHROMATOGRAPHIC ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOSPHOLIPIDS; POLYDISPERSITY; SOLUBILITY; SURFACE ACTIVE AGENTS; WAXES; ZETA POTENTIAL;

NANOPARTICLES;

CARNAUBA WAX; EMULSIFYING AGENT; KETOPROFEN; NANOPARTICLE; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; PROPOLIS; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; WAX;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STORAGE; DRUG SYNTHESIS; ENTHALPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; THERMAL ANALYSIS; THERMOGRAPHY;

CALORIMETRY, DIFFERENTIAL SCANNING; KETOPROFEN; LIPIDS; NANOPARTICLES; SURFACE-ACTIVE AGENTS; WAXES;

EID: 78649893665     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2010.06.003     Document Type: Article

References (31)

1. Hou D., Xie C., Huang K., Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003, 24:1781-1785.
2. Li Y., Dong L., Jia A., Chang X., Xue H. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int J Biol Macromol 2006, 38:296-299.
3. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 2000, 50:161-177.
4. Müller R.H., Keck C.M. Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 2004, 113:151-170.
5. Mühlen A.Z., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm 1997, 45:149-155.
6. Mehnert W., Mäder K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev 2001, 47:165-196.
7. Lim S.J., Kim C.K. Formulation parameters determining the physiochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002, 243:135-146.
8. Kim B.D., Na K., Choi H.K. Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur J Pharm Sci 2005, 24:199-205.
9. Nurse's drug handbook 1993, 557-558. W.B. Saunders Company, Philadelphia. B.B. Hodgson, R.J. Kizior, R. Kingdon (Eds.).
10. Nursing 2008 drug handbook 2008, 382-383. Wolters Kluwer Health, Philadelphia. 28th ed. R.M. Doyle (Ed.).
11. Üner M., Gönüllü Ü., Yener G., Altmkurt T. A new approach for preparing controlled release ketoprofen tablets by using beeswax. Il Farmaco 2004, 60:27-31.
12. Meastrelli F., González-Rodríguez M.L., Rabasco A.M., Mura P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm 2006, 312:53-60.
13. Arida A.I., Al-Tabakha M.M. Encapsulation of ketoprofen for controlled drug release. Eur J Pharm Biopharm 2007, 66:48-54.
14. 2. J Supercrit Fluids 2006, 42:378-384.
15. Vergote G.J., Vervate C., Van Driessche I., Hoste S., De Smedt S., Demeester J., et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm 2001, 219:81-87.
16. Vergote G.J., Vervate C., Van Driessche I., Hoste S., De Smedt S., Demeester J., et al. In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen. Int J Pharm 2002, 240:79-84.
17. Paolino D., Ventura C.A., Nistico S., Puglisi G., Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 2002, 244:21-31.
18. Valenta C., Wanka M., Heidlas J. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug. J Control Release 1999, 63:165-173.
19. Chattopadhyay P., Shekunov B.Y., Yim D., Cipolla D., Boyd B., Farr S. Production of solid lipid nanoparticle suspensions (SFEE) for pulmonary delivery using AERx system. Adv Drug Deliv Rev 2007, 59:444-453.
20. Ugazio E., Cavalli R., Gasco M.R. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int J Pharm 2002, 241:341-344.
21. Liu J., Gong T., Wang C., Zhong Z., Zhang Z.R. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine based mixed micelles: preparation and characterization. Int J Pharm 2007, 340:153-162.
22. Westesen K., Siekmann B., Koch M.H.J. Investigation on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int J Pharm 1993, 93:189-199.
23. Schubert M.A., Muller-Goymann C.C. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm 2005, 61:77-86.
24. Myers D. Surfactant science and technology 2006, 380. Wiley, Hoboken: NJ. 3rd ed.
25. Attama A.A., Müller-Goymann C.C. Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloids Surf A 2008, 315:189-195.
26. Attama A.A., Müller-Goymann C.C. Characterization of solid lipid nanoparticles with mixed lipid core for controlled drug delivery applications. Eur J Pharm Biopharm 2007, 67:48-57.
27. Cavalli R., Peiraa E., Caputo O., Gasco M.R. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with B-cyclodextrins. Int J Pharm 1999, 182:59-69.
28. Lv Q., Yu A., Xi Y., Li H., Song Z., Cui J., et al. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm 2009, 372:191-198.
29. Ölbrich C., Müller R.H. Enzymatic degradiation of SLN-effect of surfactant and surfactant mixtures. Int J Pharm 1999, 180:31-39.
30. Hurrell S., Cameron R.E. The effect of buffer concentration, pH and buffer ions on the degradation and drug release from polyglycolide. Polym Int 2003, 52:358-366.
31. Özyazici M., Gökçe E.H., Ertan G. Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm 2006, 63:331-339.